These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 12691603

  • 21. Feedback inhibition by RALT controls signal output by the ErbB network.
    Anastasi S, Fiorentino L, Fiorini M, Fraioli R, Sala G, Castellani L, Alemà S, Alimandi M, Segatto O.
    Oncogene; 2003 Jul 03; 22(27):4221-34. PubMed ID: 12833145
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation.
    Koziolek EJ, Donoghue JF, Bentley JD, Lovrecz G, Dolezal O, Ward CW, Rothacker J, Nice EC, Burgess AW, Hafner M, Johns TG, Adams TE.
    Growth Factors; 2012 Oct 03; 30(5):310-9. PubMed ID: 22856597
    [Abstract] [Full Text] [Related]

  • 26. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
    Yang C, Liu Y, Lemmon MA, Kazanietz MG.
    Mol Cell Biol; 2006 Feb 03; 26(3):831-42. PubMed ID: 16428439
    [Abstract] [Full Text] [Related]

  • 27. Erk1/2 phosphorylation and reactive oxygen species formation via nitric oxide and Akt-1/Raf-1 crosstalk in cultured rat cerebellar granule cells exposed to the organic solvent 1,2,4-trimethylcyclohexane.
    Myhre O, Sterri SH, Bogen IL, Fonnum F.
    Toxicol Sci; 2004 Aug 03; 80(2):296-303. PubMed ID: 15141098
    [Abstract] [Full Text] [Related]

  • 28. Regulation of Na+ transport by aldosterone: signaling convergence and cross talk between the PI3-K and MAPK1/2 cascades.
    Tong Q, Booth RE, Worrell RT, Stockand JD.
    Am J Physiol Renal Physiol; 2004 Jun 03; 286(6):F1232-8. PubMed ID: 15039143
    [Abstract] [Full Text] [Related]

  • 29. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.
    Jackson JG, St Clair P, Sliwkowski MX, Brattain MG.
    Cancer Res; 2004 Apr 01; 64(7):2601-9. PubMed ID: 15059917
    [Abstract] [Full Text] [Related]

  • 30. Heregulin regulation of Akt/protein kinase B in breast cancer cells.
    Liu W, Li J, Roth RA.
    Biochem Biophys Res Commun; 1999 Aug 11; 261(3):897-903. PubMed ID: 10441522
    [Abstract] [Full Text] [Related]

  • 31. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
    Rommel C, Clarke BA, Zimmermann S, Nuñez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ.
    Science; 1999 Nov 26; 286(5445):1738-41. PubMed ID: 10576741
    [Abstract] [Full Text] [Related]

  • 32. Akt-mediated survival of oligodendrocytes induced by neuregulins.
    Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, Okamoto T, Macklin WB.
    J Neurosci; 2000 Oct 15; 20(20):7622-30. PubMed ID: 11027222
    [Abstract] [Full Text] [Related]

  • 33. Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain.
    Antonelli V, Bernasconi F, Wong YH, Vallar L.
    Mol Biol Cell; 2000 Apr 15; 11(4):1129-42. PubMed ID: 10749919
    [Abstract] [Full Text] [Related]

  • 34. Neuregulin signaling on glucose transport in muscle cells.
    Cantó C, Suárez E, Lizcano JM, Griñó E, Shepherd PR, Fryer LG, Carling D, Bertran J, Palacín M, Zorzano A, Gumà A.
    J Biol Chem; 2004 Mar 26; 279(13):12260-8. PubMed ID: 14711829
    [Abstract] [Full Text] [Related]

  • 35. Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells.
    Venkateswarlu S, Dawson DM, St Clair P, Gupta A, Willson JK, Brattain MG.
    Oncogene; 2002 Jan 03; 21(1):78-86. PubMed ID: 11791178
    [Abstract] [Full Text] [Related]

  • 36. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.
    Kainulainen V, Sundvall M, Määttä JA, Santiestevan E, Klagsbrun M, Elenius K.
    J Biol Chem; 2000 Mar 24; 275(12):8641-9. PubMed ID: 10722704
    [Abstract] [Full Text] [Related]

  • 37. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.
    Shelton JG, Steelman LS, White ER, McCubrey JA.
    Cell Cycle; 2004 Mar 24; 3(3):372-9. PubMed ID: 14726697
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel.
    Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishio Y, Adachi K, Takahashi K, Arimoto-Ishida E, Nakatsuji Y, Tasaka K, Murata Y.
    J Biol Chem; 2002 Sep 06; 277(36):33490-500. PubMed ID: 12087097
    [Abstract] [Full Text] [Related]

  • 39. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
    Puricelli L, Proietti CJ, Labriola L, Salatino M, Balañá ME, Aguirre Ghiso J, Lupu R, Pignataro OP, Charreau EH, Bal de Kier Joffé E, Elizalde PV.
    Int J Cancer; 2002 Aug 20; 100(6):642-53. PubMed ID: 12209601
    [Abstract] [Full Text] [Related]

  • 40. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.
    Carón RW, Yacoub A, Zhu X, Mitchell C, Han SI, Sasazuki T, Shirasawa S, Hagan MP, Grant S, Dent P.
    Mol Cancer Ther; 2005 Feb 20; 4(2):243-55. PubMed ID: 15713896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.